Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancerAmritha Nair, Thomas F. Westbrook, Tingting Sun et al.|Nature Medicine|2018Cited by 83
Romidepsin (FK228) regulates the expression of the immune checkpoint ligand PD-L1 and suppresses cellular immune functions in colon cancerYehui Shi, Hui Li|Cancer Immunology Immunotherapy|2020Cited by 71
SH3BGRL confers innate drug resistance in breast cancer by stabilizing HER2 activation on cell membraneHui Li, Haihe Wang|Journal of Experimental & Clinical Cancer Research|2020Cited by 40
Inhibition of stromal MAOA leading activation of WNT5A enhance prostate cancer immunotherapy by involving the transition of cancer-associated fibroblastsZhite Zhao, Changhong Shi, Yaohua Hu et al.|Journal for ImmunoTherapy of Cancer|2025Cited by 13
HDAC6-Dependent Deacetylation of TAK1 Enhances sIL-6R Release to Promote Macrophage M2 Polarization in Colon CancerHui Li, Shaowei Wang|Research Square|2022Cited by 0